ImmuneOncia Therapeutics Inc banner

Bankruptcy Probability

ImmuneOncia Therapeutics Inc's probability of bankruptcy is 1.2%, making a collapse highly unlikely. The solvency score is 75/100 — a strong indicator of financial stability.

We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.

Very Low
Probability of Bankruptcy

Financial Position

Cash & Short-Term Investments
+
Jun 30, 2026 93.2B
Mar 31, 2026 19B
Dec 31, 2025 23.4B
Long-Term Investments
+
Jun 30, 2026 0
Mar 31, 2026 0
Dec 31, 2025 0
Debt
+
Jun 30, 2026 10.1m
Mar 31, 2026 12.4m
Dec 31, 2025 14.6m

Solvency Ratios

Solvency Ratios Comparison
ImmuneOncia Therapeutics Inc Competitors

Country Company Market Cap D/E D/A Interest
Coverage
Altman
Z-Score
Quick
Ratio
Current
Ratio
Cash
Ratio
KR
ImmuneOncia Therapeutics Inc
KOSDAQ:424870
214B KRW
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
AbbVie Inc
NYSE:ABBV
501.2B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
236B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences, Inc
NASDAQ:GILD
206.7B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
132B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
98.3B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Moderna Inc
NASDAQ:MRNA
80.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
53.7B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
88.4B AUD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Natera Inc
NASDAQ:NTRA
41.6B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Biogen Inc
NASDAQ:BIIB
36.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Is ImmuneOncia Therapeutics Inc at risk of bankruptcy?

ImmuneOncia Therapeutics Inc's probability of bankruptcy is 1.2%, making a collapse highly unlikely.

The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does ImmuneOncia Therapeutics Inc have?

As of the latest report, ImmuneOncia Therapeutics Inc has total debt of 10.1m KRW. This includes both short-term (0 KRW) and long-term (10.1m KRW) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top